would wish [15:10%: Endocrine & metabolic: Hypoglycemia (combination therapy; 3% to 17%) Gastrointestinal: Diarrhea (13%), nausea (11%) Local: Injection site reaction (11% to 18%, including erythema at injection site [2%], hypersensitivity reaction at injection site [1%], rash at injection site [1%], itching at injection site) Respiratory: Upper respiratory tract infection (14%) 1% to 10%: Cardiovascular: Atrial fibrillation (1%) Endocrine & metabolic: Increased gamma-glutamyl transferase (2%) Gastrointestinal: Gastroesophageal reflux disease (4%), vomiting (4%) Immunologic: Antibody development (non-neutralizing; 6%) Infection: Influenza (5%) Neuromuscular & skeletal: Arthralgia (7%), back pain (7%) Respiratory: Cough (7%), pneumonia (2%)] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Albiglutide Rating 11 User Reviews 4.6 /10 11 User Reviews 4.6 Rate it! Drug Class Incretin mimetics Related Drugs incretin mimetics Victoza , Trulicity , Bydureon , Byetta , liraglutide , Saxenda Diabetes, Type 2 metformin , insulin aspart , glipizide , glimepiride , Januvia , pioglitazone , Victoza , Actos , Tradjenta , Glucophage , glyburide , Janumet , Invokana , Amaryl , Welchol , Onglyza , sitagliptin , Trulicity , Jardiance , Lantus , Farxiga , Levemir , Tresiba , Glucotrol , Bydureon , More... hiking
and you will Albiglutide of pretend
EmoticonEmoticon